Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/22/2025 | $414.00 | Outperform | Bernstein |
| 4/15/2025 | $375.00 | Outperform → Neutral | Robert W. Baird |
| 3/5/2025 | $295.00 → $372.00 | Equal Weight → Overweight | Wells Fargo |
| 12/17/2024 | $378.00 → $350.00 | Neutral | Analyst |
| 5/30/2024 | $405.00 | Outperform | Robert W. Baird |
| 3/28/2024 | $439.00 | Neutral → Underperform | BofA Securities |
| 3/6/2024 | $437.00 | Equal Weight | Barclays |
| 2/15/2024 | $367.00 → $420.00 | Underweight → Equal Weight | Wells Fargo |
Reaffirms Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported first quarter 2025 GAAP earnings per diluted share of $5.45 and adjusted earnings per diluted share of $6.08. Financial results are summarized below: Three months ended March 31, 2025 2024 (In millions, except per-share results) Premium Revenue $10,628 $9,504 Total Revenue $11,147 $9,931 GAAP: Net Income $298 $301 EPS – Diluted $5.45 $5.17 Medical Care Ratio (MCR) 89.2% 88.5% G&A Ratio 6.9% 7.2
Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") announced today that the Company's subsidiary, Molina Healthcare of Illinois, Inc., was one of four managed care organizations awarded a contract by the Illinois Department of Healthcare and Family Services to provide a Fully Integrated Dual Eligible Special Needs Plan (D-SNP). This contract will replace the State's Medicare-Medicaid Alignment Initiative (MMAI) demonstration program, which currently serves approximately 73,000 beneficiaries. The go-live date for the new contract is expected to be January 1, 2026. The contract is expected to have an initial term of four years, with the option to extend the contract from the init
Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the first quarter ending March 31, 2025, after the market closes on Wednesday, April 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, April 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 3317326. A telephonic replay of the conference call will be available through Thursday, May 1, 2025, by dialing (877) 344-7529 and entering the confirmation number, 6106565. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relations
Bernstein initiated coverage of Molina Healthcare with a rating of Outperform and set a new price target of $414.00
Robert W. Baird downgraded Molina Healthcare from Outperform to Neutral and set a new price target of $375.00
Wells Fargo upgraded Molina Healthcare from Equal Weight to Overweight and set a new price target of $372.00 from $295.00 previously
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
3 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
SCHEDULE 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
S-8 - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
Reaffirms Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported first quarter 2025 GAAP earnings per diluted share of $5.45 and adjusted earnings per diluted share of $6.08. Financial results are summarized below: Three months ended March 31, 2025 2024 (In millions, except per-share results) Premium Revenue $10,628 $9,504 Total Revenue $11,147 $9,931 GAAP: Net Income $298 $301 EPS – Diluted $5.45 $5.17 Medical Care Ratio (MCR) 89.2% 88.5% G&A Ratio 6.9% 7.2
Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the first quarter ending March 31, 2025, after the market closes on Wednesday, April 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, April 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 3317326. A telephonic replay of the conference call will be available through Thursday, May 1, 2025, by dialing (877) 344-7529 and entering the confirmation number, 6106565. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relations
Introduces Full Year 2025 Revenue and Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported fourth quarter 2024 GAAP earnings per diluted share of $4.44 and adjusted earnings per diluted share of $5.05. The Company also reported full year 2024 GAAP earnings per diluted share of $20.42 and adjusted earnings per diluted share of $22.65. Financial results are summarized below: Three months ended Year ended December 31, December 31, 2024 2023 2024 2023 (In millions, except per-s
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)